Pharmafile Logo

Are you suffering from templatitis?

May 16, 2017 |  

- PMLiVE
At times, it feels like procedures are designed to frustrate, and templates often hinder rather than help. Especially in strategic planning, where a certain degree of creativity and innovation is required to move a business forward, templates can be the death of progress.

Duncan Ferguson, managing director of the Lucid Strategic Consultancy, calls this – templatitis. Especially in a market as complex and diverse as pharma, templated approaches to business strategy can stand in the way of fresh thinking. “It is no wonder that the challenge of reflecting our heterogenous strategic plans in homogenous templates is causing such traumatic symptoms”, posits Duncan. 

In Duncan’s recent blog for PMLIVE he proposes three approaches to combat templatitis, which you can read more about here.

 If your business suffers from templatitis and is in need of a strategic overhaul, you can get in touch with Duncan at duncan@lucid-group.co.uk or on +44 (0)1494 755707

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid celebrate big wins at PMEA 2015

Success for Lucid at PMEA 2015

Lucid invests in their Futures programme with a new hire

Lucid Group continues their expansion

Janus kinase inhibitors are amongst the most read abstracts at the American College of Rheumatology 2015

Rheumatologists eagerly await trial data for Janus kinase inhibitors

Making a difference to patients with IBD

Changing lives with medical education

Lucid Group showcases new KOL identification and mapping tool

Advancing Expert identification with digital new tool from Lucid Group

Lucid CEO discusses his inspiration and passion for changing patients’ lives

Changing patients' lives with innovative methodologies in medical education

Lucid Group starts new trend for CME in IBD education

A tailored educational event in IBD